Patents by Inventor Yongquan Shen

Yongquan Shen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9809631
    Abstract: Lectin compositions and methods for reducing tumor cell growth and preventing or treating cancer are provided.
    Type: Grant
    Filed: October 23, 2015
    Date of Patent: November 7, 2017
    Inventors: Gary S. Goldberg, Yongquan Shen
  • Publication number: 20160207968
    Abstract: Lectin compositions and methods for reducing tumor cell growth and preventing or treating cancer are provided.
    Type: Application
    Filed: October 23, 2015
    Publication date: July 21, 2016
    Applicant: Rowan University
    Inventors: Gary S. Goldberg, Yongquan Shen
  • Patent number: 9169327
    Abstract: Lectin compositions and methods for reducing tumor cell growth and preventing or treating cancer are provided.
    Type: Grant
    Filed: August 26, 2011
    Date of Patent: October 27, 2015
    Assignee: Rowan University
    Inventors: Gary S. Goldberg, Yongquan Shen
  • Patent number: 8114593
    Abstract: Using gene expression analysis, specific biomarker genes and gene products have been identified which are activated in transformed cells, but suppressed in nontransformed cells; or suppressed in transformed cells, but activated in transformed cells affected by Contact Normalization. Thus, the present invention features compositions and methods for detecting, diagnosing, treating and prognosing cancer.
    Type: Grant
    Filed: March 11, 2009
    Date of Patent: February 14, 2012
    Assignee: University of Medicine and Dentistry of New Jersey
    Inventors: Gary S. Goldberg, Yongquan Shen
  • Publication number: 20120010152
    Abstract: Lectin compositions and methods for reducing tumor cell growth and preventing or treating cancer are provided.
    Type: Application
    Filed: August 26, 2011
    Publication date: January 12, 2012
    Applicant: University of Medicine and Dentistry of New Jersey
    Inventors: Gary S. Goldberg, Yongquan Shen
  • Publication number: 20090232814
    Abstract: Using gene expression analysis, specific biomarker genes and gene products have been identified which are activated in transformed cells, but suppressed in nontransformed cells; or suppressed in transformed cells, but activated in transformed cells affected by Contact Normalization. Thus, the present invention features compositions and methods for detecting, diagnosing, treating and prognosing cancer.
    Type: Application
    Filed: March 11, 2009
    Publication date: September 17, 2009
    Inventors: Gary S. Goldberg, Yongquan Shen